HealthQuill Health
A family of antimicrobial compounds can neutralise necrotising fasciitis, a deadly bacterial skin infection that is also known as flesh-eating disease, when tested in mice, according to researchers at the Washington University School of Medicine in St. Louis.
Drugs Health Pharma

Scientists develop potential compound to neutralise flesh-eating bacteria

A family of antimicrobial compounds can neutralise necrotising fasciitis, a deadly bacterial skin infection that is also known as flesh-eating disease, when tested.

Read More
A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the current guidelines for cholesterol and high blood pressure treatment remain the same, according to a Harvard Medical School study.
Drugs Health Pharma

New cardiovascular risk calculator may impose a burden on 16 million US citizens

HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the.

Read More
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Drugs Health Pharma

Contineum’s test drug may reverse multiple sclerosis damage

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

Read More
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia, projected to affect 153 million people by 2050.
Drugs Health Pharma

Untreated vision loss, high LDL cholesterol risk factors for dementia

Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.

Read More
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Drugs Health Pharma

GenX faces a higher risk of 17 cancer types than older generation

Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.

Read More
WHO issues global warning on drug-resistant Klebsiella Pneumonie pathogen
Drugs Health Pharma

WHO warns on drug-resistant Klebsiella Pneumonie spread

HQ Team August 4, 2024: The WHO has warned about the rising global incidence of hypervirulent and multi-resistant Klebsiella Pneumoniae (hvKp) infections. The.

Read More
The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.
Drugs Health Pharma

US regulator allows GSK’s endometrial cancer therapy for expanded use

The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.

Read More
UK-based biopharmaceutical company, Adaptimmune Therapeutics Plc, got FDA approval for its cell therapy for treating a rare form of cancer.
Drugs Health Pharma

Adaptimmune’s therapy to treat rare form of cancer gets USFDA nod

UK-based biopharmaceutical company, Adaptimmune Therapeutics Plc, got FDA approval for its cell therapy for treating a rare form of cancer.

Read More
Climate Health Pharma

Africa grapples with a 160% spike in Mpox cases, vaccines a damper

HQ Team August 2, 2024: Mpox or monkeypox cases have seen a 160% surge in the African region this year compared to the.

Read More
The US requires a warning label on social media platforms as they are significantly associated with “mental health harms” for adolescents, the United States Surgeon General, Dr Vivek Murthy wrote in an op-ed piece in the New York Times.
Climate Drugs Health

Millennials, Gen X are at elevated risk of developing cancer than older generations

HQ Team August 2, 2024:Cancer risk is higher among the younger generation than the older ones, according to a new study. Millennials and.

Read More